Morgan Stanley lowered shares of Afya (NASDAQ:AFYA – Free Report) from an equal weight rating to an underweight rating in a research report report published on Tuesday morning, Marketbeat reports. Morgan Stanley currently has $17.00 price target on the stock, down from their prior price target of $19.00.
Other analysts have also recently issued research reports about the company. The Goldman Sachs Group began coverage on Afya in a research report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 target price for the company. JPMorgan Chase & Co. decreased their price objective on Afya from $25.00 to $20.50 and set a “neutral” rating for the company in a research report on Friday, January 17th. Finally, Citigroup restated a “sell” rating and set a $15.00 price objective (down from $18.00) on shares of Afya in a research report on Friday, January 31st. Three research analysts have rated the stock with a sell rating and two have given a hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $17.60.
Read Our Latest Stock Report on Afya
Afya Trading Down 6.4 %
Institutional Trading of Afya
A number of institutional investors have recently bought and sold shares of AFYA. Quantbot Technologies LP lifted its holdings in shares of Afya by 73.8% during the 3rd quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock valued at $226,000 after buying an additional 5,636 shares during the last quarter. PDT Partners LLC acquired a new stake in Afya in the third quarter valued at approximately $481,000. Erste Asset Management GmbH acquired a new stake in Afya in the third quarter valued at approximately $822,000. Centiva Capital LP acquired a new stake in Afya in the third quarter valued at approximately $213,000. Finally, Point72 Asset Management L.P. acquired a new stake in shares of Afya in the 3rd quarter valued at $842,000. Institutional investors and hedge funds own 88.02% of the company’s stock.
About Afya
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Recommended Stories
- Five stocks we like better than Afya
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to Buy Cheap Stocks Step by Step
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.